Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.

This can be an important add-on to echocardiography in patients with a borderline need for intervention, researchers say.

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

The multidisciplinary care required to treat these complex patients is most often found in higher-volume centers.

Telling patients how many extra days they’ll be free from an event can help with shared decision-making, experts say.

Individuals assigned male at birth who were pushed to change their identity had more inflammation and higher blood pressure.

The novel CETP inhibitor, once tested for the now-defunct pathway of HDL raising, reduces LDL as well as Lp(a).

With its twice-yearly dosing, the siRNA-based drug might lead to better compliance with treatment. Still, cost is an issue.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

By group, procedural success and freedom from LVOT obstruction (LVOT mean gradient > 50 mm Hg), the primary efficacy endpoint ...

With both new and revised measures, the document’s authors aim to provide clinicians usable advice in a digestible format.

Approximately one in four patients died, deteriorated to a higher shock stage, or were transferred for a higher level of care ...